Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients is a research paper published in The Annals of Thoracic Surgery (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
US Department of Veterans Affairs
Grant: I01 BX002299
National Institute of Allergy and Infectious Diseases
Grant: R01AI145108 -01
National Institute of Allergy and Infectious Diseases
Grant: P01AI116501
National Heart, Lung, and Blood Institute
Grant: R01HL166402
National Heart, Lung, and Blood Institute
Grant: R01HL128492
NIH
FWCI
1.76
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals